Found 5 matching trials
Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) PHASE2 A single-center, double-blind, placebo-controlled study of FDC olopatadine ...
Show More Location
Glenmark Investigational Site 1
Learn More & Join Trial
To Study GSP 301 in Patients With Seasonal Allergic Rhinitis PHASE2 Study to evaluate the two different strengths and dose regimen of GSP 301 t...
Show More Location
Glenmark Investigational Site 10
Learn More & Join Trial
Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) PHASE3 Study to evaluate the efficacy, safety and tolerability of GSP 301 NS compa...
Show More Location
Investigational Site 406
Learn More & Join Trial
Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) PHASE3 Study to evaluate the efficacy and safety of GSP 301 NS compared to placebo...
Show More Location
Investigational Site 20
Learn More & Join Trial
Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) PHASE3 To evaluate the long term safety and efficacy of GSP 301 NS compared to 2 p...
Show More Location
Investigational Site 2
Learn More & Join Trial